Captodiame is a first-generation antihistamine acting as an H1 receptor antagonist, historically utilized for its sedative and anxiolytic properties in the treatment of conditions such as allergic rhinitis… Read more
Captodiame is a first-generation antihistamine acting as an H1 receptor antagonist, historically utilized for its sedative and anxiolytic properties in the treatment of conditions such as allergic rhinitis and urticaria. This category offers high-quality reference standards for Captodiame, including associated pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. Pharmaceutical laboratories rely on these specialized materials for rigorous impurity profiling, method validation, and consistent quality control throughout drug development and manufacturing processes. By utilizing these precise analytical standards, researchers can accurately identify, quantify, and characterize potential degradants and related substances, ensuring compliance with regulatory requirements. Accessing comprehensive sets of these compounds is essential for maintaining the integrity and safety of pharmaceutical products in both research and routine analysis settings.